000 | 01463 a2200385 4500 | ||
---|---|---|---|
005 | 20250513144112.0 | ||
264 | 0 | _c19980728 | |
008 | 199807s 0 0 eng d | ||
022 | _a0168-8278 | ||
024 | 7 |
_a10.1016/s0168-8278(98)80223-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBernhard, M C | |
245 | 0 | 0 |
_aTime course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine. _h[electronic resource] |
260 |
_bJournal of hepatology _cMay 1998 |
||
300 |
_a751-5 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcysteine _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aCysteine _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlutathione _xblood |
650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
650 | 0 | 4 |
_aHomocysteine _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJunker, E | |
700 | 1 | _aHettinger, A | |
700 | 1 | _aLauterburg, B H | |
773 | 0 |
_tJournal of hepatology _gvol. 28 _gno. 5 _gp. 751-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-8278(98)80223-7 _zAvailable from publisher's website |
999 |
_c9591700 _d9591700 |